Astrana Health, Inc.
ASTH · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $2 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $0 | $0 | $0 |
| Enterprise Value | $2 | $1 | $2 | $2 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 46% | 5.5% | -6.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 8.5% | 11.9% | 11.5% | 9.5% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 4.1% | 4.8% | 3.8% | 2.1% |
| Net Income | $0 | $0 | $0 | -$0 |
| % Margin | 0% | 1.4% | 1.1% | -1% |
| EPS Diluted | -0.33 | 0.19 | 0.14 | -0.14 |
| % Growth | -273.7% | 35.7% | 200% | – |
| Operating Cash Flow | $0 | $0 | $0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | -$0 |